drugset / Trial / NCT04996823
Axitinib + Ipilimumab in Advanced Melanoma
NaSingle-groupOpen-labelTreatment
Summary
The goal of this clinical research study is to find out if taking axitinib with ipilimumab is effective in treating advanced melanoma.
Timeline
- Start
- 2021-08-04
- Primary completion
- 2026-08-20
- Completion
- 2027-03-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Axitinib | Small molecule | 5 mg | Oral |
| Subject | Ipilimumab | Monoclonal antibody | 3 mg/kg | Intravenous |